114 related articles for article (PubMed ID: 7670136)
1. The bcl-2 and p53 oncoproteins can be modulated by bryostatin 1 and dolastatins in human diffuse large cell lymphoma.
Maki A; Diwakaran H; Redman B; al-Asfar S; Pettit GR; Mohammad RM; al-Katib A
Anticancer Drugs; 1995 Jun; 6(3):392-7. PubMed ID: 7670136
[TBL] [Abstract][Full Text] [Related]
2. Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphoma.
Mohammad RM; Diwakaran H; Maki A; Emara MA; Pettit GR; Redman B; al-Katib A
Leuk Res; 1995 Sep; 19(9):667-73. PubMed ID: 7564478
[TBL] [Abstract][Full Text] [Related]
3. Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts.
Al-Katib AM; Smith MR; Kamanda WS; Pettit GR; Hamdan M; Mohamed AN; Chelladurai B; Mohammad RM
Clin Cancer Res; 1998 May; 4(5):1305-14. PubMed ID: 9607591
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bcl-2.
Mohammad RM; Beck FW; Katato K; Hamdy N; Wall N; Al-Katib A
Biol Chem; 1998 Oct; 379(10):1253-61. PubMed ID: 9820586
[TBL] [Abstract][Full Text] [Related]
5. Bax:Bcl-2 ratio modulation by bryostatin 1 and novel antitubulin agents is important for susceptibility to drug induced apoptosis in the human early pre-B acute lymphoblastic leukemia cell line, Reh.
Wall NR; Mohammad RM; Al-Katib AM
Leuk Res; 1999 Oct; 23(10):881-8. PubMed ID: 10573132
[TBL] [Abstract][Full Text] [Related]
6. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
[TBL] [Abstract][Full Text] [Related]
7. Synergistic interaction of selected marine animal anticancer drugs against human diffuse large cell lymphoma.
Mohammad RM; Pettit GR; Almatchy VP; Wall N; Varterasian M; Al-Katib A
Anticancer Drugs; 1998 Feb; 9(2):149-56. PubMed ID: 9510501
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of bryostatin 1 on human non-Hodgkin's B-lymphoma cell lines.
Mohammad RM; al-Katib A; Pettit GR; Sensenbrenner LL
Leuk Res; 1993 Jan; 17(1):1-8. PubMed ID: 8429674
[TBL] [Abstract][Full Text] [Related]
9. Bryostatin 1 (bryo1)-induced monocytic differentiation in THP-1 human leukemia cells is associated with enhanced c-fyn tyrosine kinase and M-CSF receptors.
Li Y; Mohammad RM; al-Katib A; Varterasian ML; Chen B
Leuk Res; 1997 May; 21(5):391-7. PubMed ID: 9225065
[TBL] [Abstract][Full Text] [Related]
10. Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.
Wall NR; Mohammad RM; Nabha SM; Pettit GR; Al-Katib AM
Biochem Biophys Res Commun; 1999 Dec; 266(1):76-80. PubMed ID: 10581168
[TBL] [Abstract][Full Text] [Related]
11. p53 and protein kinase C independent induction of growth arrest and apoptosis by bryostatin 1 in a highly metastatic mammary epithelial cell line: In vitro versus in vivo activity.
Wang H; Mohammad RM; Werdell J; Shekhar PV
Int J Mol Med; 1998 Jun; 1(6):915-23. PubMed ID: 9852625
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment of human chronic lymphocytic leukemia xenografts with combination biological agents auristatin PE and bryostatin 1.
Mohammad RM; Varterasian ML; Almatchy VP; Hannoudi GN; Pettit GR; Al-Katib A
Clin Cancer Res; 1998 May; 4(5):1337-43. PubMed ID: 9607595
[TBL] [Abstract][Full Text] [Related]
13. Bryostatin 1 induces differentiation and potentiates the antitumor effect of Auristatin PE in a human pancreatic tumor (PANC-1) xenograft model.
Mohammad RM; Adsay NV; Philip PA; Pettit GR; Vaitkevicius VK; Sarkar FH
Anticancer Drugs; 2001 Oct; 12(9):735-40. PubMed ID: 11593055
[TBL] [Abstract][Full Text] [Related]
14. Bryostatin 1 induces ubiquitin COOH-terminal hydrolase in acute lymphoblastic leukemia cells.
Mohammad RM; Maki A; Pettit GR; al-Katib AM
Enzyme Protein; 1996; 49(5-6):262-72. PubMed ID: 9252784
[TBL] [Abstract][Full Text] [Related]
15. Dolastatin 10 and dolastatin 15: effects of two natural peptides on growth and differentiation of leukemia cells.
Steube KG; Grunicke D; Pietsch T; Gignac SM; Pettit GR; Drexler HG
Leukemia; 1992 Oct; 6(10):1048-53. PubMed ID: 1405759
[TBL] [Abstract][Full Text] [Related]
16. Growth inhibition of human lymphoma cell lines by the marine products, dolastatins 10 and 15.
Beckwith M; Urba WJ; Longo DL
J Natl Cancer Inst; 1993 Mar; 85(6):483-8. PubMed ID: 8445676
[TBL] [Abstract][Full Text] [Related]
17. Activation of the MEK/MAPK pathway is involved in bryostatin1-induced monocytic differenciation and up-regulation of X-linked inhibitor of apoptosis protein.
Lin H; Chen C; Li X; Chen BD
Exp Cell Res; 2002 Jan; 272(2):192-8. PubMed ID: 11777344
[TBL] [Abstract][Full Text] [Related]
18. Agents that down-regulate or inhibit protein kinase C circumvent resistance to 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human leukemia cells that overexpress Bcl-2.
Wang S; Vrana JA; Bartimole TM; Freemerman AJ; Jarvis WD; Kramer LB; Krystal G; Dent P; Grant S
Mol Pharmacol; 1997 Dec; 52(6):1000-9. PubMed ID: 9396780
[TBL] [Abstract][Full Text] [Related]
19. Induced expression of alpha-enolase in differentiated diffuse large cell lymphoma.
Mohammad RM; Hamdan MY; al-Katib A
Enzyme Protein; 1994-1995; 48(1):37-44. PubMed ID: 7787969
[TBL] [Abstract][Full Text] [Related]
20. Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.
Ali MA; Rosati R; Pettit GR; Kalemkerian GP
Anticancer Res; 1998; 18(2A):1021-6. PubMed ID: 9615758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
